Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma

This publication has 11 references indexed in Scilit:

• Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
  CA: A Cancer Journal for Clinicians, 2017
• Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases
  Journal of the American Academy of Dermatology, 2017
• Tumor Mitotic Rate Added to the Equation: Melanoma Prognostic Factors Changed?
  Annals of Surgical Oncology, 2015
• Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study
  British Journal of Dermatology, 2014
• Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database
  Journal of Clinical Oncology, 2011
• Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?
  The American Journal of Surgery, 2010
• The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma
  Journal of Cutaneous Pathology, 2005
• The Prognostic Importance of Tumor Mitotic Rate Confirmed in 1317 Patients With Primary Cutaneous Melanoma and Long Follow-Up
  Annals of Surgical Oncology, 2004
• Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model
  Annals of Surgical Oncology, 2004
• Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma
  Cancer, 2003